FORMULATION, OPTIMIZATION AND IN VITRO CHARACTERIZATION OF STAVUDINE GASTRO RETENTIVE FLOATING MATRIX TABLETS
Abstract
The aim of the present investigation was to develop floating matrix tablets of stavudine to achieve prolong gastric residence time, leading to an increase in drug bioavailability and patient compliance. Floating tablets were prepared by wet granulation technique, using hydroxypropyl methylcellulose (HPMC K15M) as synthetic, pullulan gum as natural rate controlling polymers and optimum amounts of sodium-bicarbonate and citric acid as gas generating agents in suitable ratios to generate optimum buoyancy. Developed formulations were evaluated for weight variation, thickness, hardness, friability, drug content, in vitro drug release, floating lag time and floating buoyancy. All the formulations exhibited acceptable physical properties and the best formulation (F3) was selected based on in vitro characteristics. Further, the optimized formulation was evaluated for in vivo radiographic studies by incorporating BaSO4 as radio opaque substance. All the formulations were studied for in vitro drug release characteristics for 16 h. Optimized formulation showed controlled and prolonged drug release profiles while floating over the dissolution medium. Diffusion followed by erosion drug release mechanism was observed for the formulation, indicating that water diffusion and polymer erosion played an essential role in drug release. In vivo radiographic studies revealed that the tablets remained in the stomach for 8 ± 0.5 h in fasting human volunteers and indicated that gastric retention time was increased by the floating principle, which was considered and desirable for absorption window drugs.
Keywords:
Floating matrix tablets, stavudine, gastric residence time, floating lag time, In vivo radiographic studiesDOI
https://doi.org/10.25004/IJPSDR.2016.080309References
2. Rouge N, Allemann E, Gex-Fabry M, Balant L, Cole ET, Buri P, Doelker E. Comparative pharmacokinetic studies of a floating multiple-unit capsule, a high density multiple unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm ActaHelbetiae. 1998; 73:81-87.
3. Streubel A, Siepmann J, Bodmeier R. Multiple unit Gastroretentive drug delivery: a new preparation method for low density microparticles. J Microencapsul. 2003; 20:329-347.
4. Goole J, Vanderbist F, Aruighi K. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int J Pharm. 2007; 334:35-41.
5. Sharma S, Pawar A. Low density multiparticulate systemfor pulsatile release of meloxicam. Int J Pharm. 2006; 313:150-158.
6. Santus G, Lazzarini G, Bottoni G, Sandefer EP, Page RC, Doll WJ, Ryo UY, Digenis GA. An in vitro- in vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur J Pharm Biopharm. 1997; 44:39-52.
7. Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosage forms. J Control Rel. 2003; 90:143-162.
8. Deshpande AA, Shah N, Rhodes CT, Malik W. Development of a novel controlled-release system for gastric retention. Pharm Res. 1997; 14:815-819.
9. Park K. Enzyme-digestible swelling as platforms for long term oral drug delivery: synthesis and characterization. Biomaterials. 1988; 9:435-439.
10. Fujimori J, Machida Y, Nagai T. Preparation of amagnetically-responsive tablet and configuration of its gastric residence in beagle dogs. STP Pharma Sci. 1994; 4:425-430.
11. Davis SS, Stockwell AF, Taylor MJ, John GH, David RW, Wilson CG. The effect of density on the gastric emptying of single and multiple unit dosage forms. Pharm Res. 1986; 3:208‑213.
12. Arrora S, Ali J, Khar RK, Baboota S. Floating drug delivery systems: A review. AAPS Pharm Sci Tech. 2005; 6:372‑390.
13. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspensions. J. Pharm. Sci. 1961; 50:874–875.
14. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983; 15:25–35.
15. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. ActaHelv. 1985; 60:110–111.
16. Chavanpatil DM, Jain P, Choudhari S, Shear R, Vavia RP. Novel sustained release, swellable and bioadhesive gastro retentive drug delivery system for Ofloxacin. Int J Pharm. 2006; 316:86‑92.
17. Patel MP, Patel MM, Patel DH, Patel KN. Formulation Development, Optimization and Evaluation of Famotidine Floating Matrix Tablets. Int. J. Pharm. Sci. Drug Res. 2009; 1(2): 85-90.
18. The Indian Pharmacopoeia. Indian Pharmacopoeia Commission, Govt. of India, Vol III. 2010.
19. Mitchell K, Ford JL, Armstrong DJ. The influence of concentration on the release of drugs from gels and matrices containing Methocel. Int. J. Pharm. 1993; 100:155–163.
20. Kamanashis D, Md. Yasin, Ishrak J, Tahira A, Saiful I, Md. Sagir Mia. Gastroretentive Drug Delivery System of Levo-Salbutamol Sulphate: Formulation and in vitro Evaluation. Int. J. Pharm. Sci. Drug Res. 2016; 8(2):87-90.
Published

